Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

SHE:002900 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 18, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,176	3,049	4,228	4,229	6,453	2,866
Market Cap Growth	-0.31%	-27.88%	-0.01%	-34.47%	125.19%	-22.59%
Enterprise Value	4,283	3,126	3,815	3,675	6,009	2,152
Last Close Price	13.49	9.71	13.19	13.09	19.47	8.62
PE Ratio	378.21	51.97	57.40	139.99	18.39	97.72
Forward PE	-	40.26	40.26	40.26	40.26	40.26
PS Ratio	3.83	2.69	3.56	4.11	6.82	2.14
PB Ratio	1.96	1.41	1.97	2.06	3.05	1.60
P/TBV Ratio	2.07	1.49	2.09	2.14	3.18	1.69
P/FCF Ratio	-	-	-	76.30	-	-
P/OCF Ratio	27.34	99.37	118.45	29.24	-	-
EV/Sales Ratio	3.93	2.76	3.22	3.57	6.35	1.61
EV/EBITDA Ratio	37.01	23.47	42.19	56.52	-	32.78
EV/EBIT Ratio	-	95.56	-	-	-	-
EV/FCF Ratio	-21.82	-	-	66.31	-	-
Debt / Equity Ratio	0.39	0.43	0.33	0.32	0.23	0.15
Debt / EBITDA Ratio	7.15	6.51	7.13	8.80	-	4.11
Debt / FCF Ratio	-	-	-	11.85	-	-
Asset Turnover	0.30	0.31	0.35	0.32	0.34	0.52
Inventory Turnover	2.03	2.15	2.57	2.27	1.82	2.43
Quick Ratio	0.78	0.86	1.36	2.38	2.32	2.01
Current Ratio	1.16	1.17	1.70	2.72	2.66	2.45
Return on Equity (ROE)	0.36%	2.55%	3.34%	1.27%	17.89%	1.46%
Return on Assets (ROA)	0.07%	0.56%	-0.15%	-0.63%	-3.38%	-0.35%
Return on Capital (ROIC)	0.08%	0.69%	-0.18%	-0.75%	-4.02%	-0.44%
Return on Capital Employed (ROCE)	0.20%	1.30%	-	-	-	-
Earnings Yield	0.26%	1.92%	1.74%	0.71%	5.44%	1.02%
FCF Yield	-4.70%	-10.35%	-6.24%	1.31%	-1.34%	-5.25%
Dividend Yield	1.48%	2.06%	1.52%	0.76%	1.64%	0.93%
Payout Ratio	1133.49%	178.20%	55.71%	361.96%	9.78%	326.66%
Buyback Yield / Dilution	-0.24%	-0.61%	-1.61%	2.74%	4.68%	-4.82%
Total Shareholder Return	1.24%	1.44%	-0.09%	3.50%	6.33%	-3.89%

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.